Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced Control of Hypertension and Thrombolysis Stroke Trial
2011-005545-12Phase 4Completed
- Sponsor
- University of Leicester
- Start
- Jan 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tissue-plasminogen activator, labetalol and nitroglycerin in ischemic stroke and hypertension (HTN) (4 arms), sponsored by University of Leicester. Started Jan 2012; status: completed.
02
Drugs
tissue-plasminogen activatorlabetalolnitroglycerin
03
Conditions
ischemic strokehypertension (HTN)
Beyond the preview
Go deeper on 2011-005545-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005545-12.